UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000045821
Receipt No. R000052308
Scientific Title A retrospective study of the outcome of hepatocellular carcinoma after liver resection
Date of disclosure of the study information 2021/10/21
Last modified on 2021/10/21 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A retrospective study of the outcome of hepatocellular carcinoma after liver resection
Acronym A retrospective study of the outcome of hepatocellular carcinoma after liver resection
Scientific Title A retrospective study of the outcome of hepatocellular carcinoma after liver resection
Scientific Title:Acronym A retrospective study of the outcome of hepatocellular carcinoma after liver resection
Region
Japan

Condition
Condition hepatocellular carcinoma
Classification by specialty
Hepato-biliary-pancreatic surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate the therapeutic efficacy of hepatic resection for hepatocellular carcinoma
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Others
Trial characteristics_2 Others
Developmental phase Not applicable

Assessment
Primary outcomes Recurrence site of hepatocellular carcinoma
Key secondary outcomes Recurrence-free survival, overall survival, Preoperative factor, operative factor

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients who underwent liver resection for initial hepatocellular carcinoma at Nara Medical University
Key exclusion criteria Death by other diseases within 5 years
Target sample size 278

Research contact person
Name of lead principal investigator
1st name Daisuke
Middle name
Last name Hokuto
Organization Nara Medical University
Division name Surgery
Zip code 634-8522
Address 840 shijyocho Kashihar Nara Japan
TEL 0744223051
Email hokuto@naramed-u.ac.jp

Public contact
Name of contact person
1st name Daisuke
Middle name
Last name Hokuto
Organization Nara Medical University
Division name Surgery
Zip code 634-8522
Address 840 shijyocho Kashihara Nara Japan
TEL 0744223051
Homepage URL
Email hokuto@naramed-u.ac.jp

Sponsor
Institute Nara Medical University
Institute
Department

Funding Source
Organization Nara Medical University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization IRB of Nara Medical University
Address 840 shijyocho Kashihara Nara Japan
Tel 0744223051
Email hokuto@naramed-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 10 Month 21 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 278
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 06 Month 30 Day
Date of IRB
2019 Year 06 Month 30 Day
Anticipated trial start date
2019 Year 06 Month 30 Day
Last follow-up date
2021 Year 09 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information 278 patients with primary HCC who underwent curative liver resection between 2000 and 2016 at Nara Medical University Hospital were retrospectively reviewed.

Management information
Registered date
2021 Year 10 Month 21 Day
Last modified on
2021 Year 10 Month 21 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052308